Skip to content

Professor Amanj Kurdi

Strathclyde Institute of Pharmacy and Biomedical Sciences

Personal statement

Back to staff profile

Personal statement

Professor Amanj Kurdi is Professor of Pharmacoepidemiology and Pharmacy Practice at the University of Strathclyde. His research focuses on the generation and application of real world evidence to evaluate the utilisation, effectiveness, safety, and value of medicines and healthcare interventions, with the aim of informing clinical practice, health policy, and regulatory decision making.

His work spans pharmacoepidemiology, drug utilisation research, medicines optimisation, medication safety, antimicrobial stewardship, and health services research. He has extensive expertise in the analysis of large-scale routinely collected healthcare data, including linked electronic health records, prescribing databases, hospital datasets, and national population-level resources. Using advanced epidemiological, statistical, and data science methods, his research examines prescribing quality, medication adherence and persistence, treatment outcomes, and the impact of health policies and clinical guidelines across a range of therapeutic areas.

Professor Kurdi has particular interests in antimicrobial resistance (AMR), antimicrobial stewardship, cardiovascular disease, diabetes, biologics and specialist medicines, and the use of real world data to support post-marketing surveillance and medicines safety monitoring. He leads and collaborates on national and international projects involving big data analytics, health informatics, and population health research, working closely with healthcare providers, policymakers, regulators, and academic partners.

He actively collaborates with researchers and institutions across the UK and internationally and contributes to several multidisciplinary research networks and initiatives. Through his research, he aims to improve the quality, safety, and sustainability of healthcare while strengthening the evidence base that supports medicines use and health policy decisions.

Back to staff profile

Prize And Awards

Honorary Professor: Recipient; 1/6/2026
External Examiner: Recipient; 24/2/2025
Top-ranked research paper in the Seventh Excellent Paper Symposium (1st Position): Recipient; 16/11/2024
Honorary Reader in Pharmacoepidemiology and Pharmacy Practice, NHS Lanarkshire, Scotland.: Recipient; 1/3/2024
Best Researcher (Poster winner): Recipient; 11/2/2024
Reproducibility Recognition by HDR UK as a member of EAVE II – Early Pandemic Evaluation and Enhanced Surveillance of COVID-19: Recipient; 31/1/2024

More prizes and awards

Back to staff profile

Publications

Utilization of immune checkpoint inhibitors for the treatment of cancer in Scotland, 2018 - 2024 : a national retrospective cohort study: Mueller Tanja, Crearie Christine, Lu Liya, Pan Jiafeng, Sneden Fraser N, Martin David, Kurdi Amanj, Thomson Catherine S, Clarke Julie, Bennie Marion; British Journal of Clinical Pharmacology Vol 92, pp. 3972-3981 (2026); https://doi.org/10.1002/bcp.70700
Evaluation of real-world safety surveillance of targeted immune-modifying therapies across immune-mediated inflammatory diseases using the "Medicines in Acute and Chronic Care in Scotland" linked data infrastructure : a study protocol and feasibility assessment: Kurdi Amanj, Millar Morven, Jarvis Lynne, McTaggart Stuart, Clayton Will, Sihota Charan, Mueller Tanja, Close Hazel, Williams Rachael, Warren-Gash Charlotte, Langan Sinéad, Sheikh Aziz, Bennie Marion; JMIR Public Health and Surveillance (2026); https://doi.org/10.2196/96019
Prevalence of antibiotic use and its appropriate prescribing in hospitals across Ghana : A systematic review and meta-analysis and the implications: Sefah Israel Abebrese, Samwel Erick, Sarkodie Emmanuel, Campbell Stephen M, Kurdi Amanj, Meyer Johanna, Chigome Audrey K, Godman Brian; Frontiers in Pharmacology (2026)
Budget impact analysis of subcutaneous infliximab (CT-P13 SC) for treating autoimmune diseases in Jordan: Mousa Rimal, Halloush Shiraz, Radaydeh Farah, Alyami Majed, Melhem Samar J, Balkhi Bander S, Kurdi Amanj Baker, Alkhatib Nimer S; Cost Effectiveness and Resource Allocation (2026); https://doi.org/10.1186/s12962-026-00825-x
Exploring hospital pharmacist perspectives on ethical considerations from automated patient prioritisation : a qualitative study: Clifford D, Wall A, Kurdi A, Bennie M; International Journal of Clinical Pharmacy Vol 48, pp. 2005-2014 (2026); https://doi.org/10.1007/s11096-026-02180-6
Data Resource profile : Medicines in Acute and Chronic Care in Scotland (MACCS): Goswami Cosmika, Mueller Tanja, Kurdi Amanj, Pearson Ewan, Bedir Khaled, Tolfrey Alexandra, Close Hazel, Bennie Marion; International Journal of Epidemiology Vol 55 (2026); https://doi.org/10.1093/ije/dyag187

More publications

Back to staff profile

Professional Activities

The International Conference on Real World Evidence (RWE) 2026: Speaker; 12/8/2026
NHS Lanarkshire Research Masterclass 5 (Academic Writing): Organiser; 17/6/2026
NHS Lanarkshire Research Masterclass 4 (Data Analysis): Organiser; 27/5/2026
NHS Lanarkshire Research Masterclass 3 (Funding): Organiser; 29/4/2026
NHS Lanarkshire Research Masterclass 2 (Protocol Development): Organiser; 11/3/2026
Cross-Faculty Connections: Growing Networks and Building Opportunities with and for Children and Young People: Participant; 26/2/2026

More professional activities

Projects

Causal AI for Personalised Alzheimer's Risk Reduction: Chauhan, Vinod Kumar (Principal Investigator) Kurdi, Amanj (Co-investigator) McGeown, William (Co-investigator) Lee, Joe (Post Grad Student); JARSS Research Excellence Award (3707); 01-Jan-2026 - 01-Jan-2029
Development of a UK Antimicrobial Registry (Phase 2): Kurdi, Amanj (Principal Investigator) Bennie, Marion (Co-investigator) Goswami, Cosmika (Co-investigator) Mueller, Tanja (Co-investigator); 01-Jan-2026 - 27-Jan-2027
Enhancing Real-World Data Analysis Skills through Transnational Education: Bridging Global Health Knowledge and Practical Applications: Kurdi, Amanj (Principal Investigator); 01-Jan-2026 - 31-Jan-2027
MHRA – Scottish Collaboration Proposal to Pilot Next-Generation Medication Surveillance and Pharmacovigilance: Bennie, Marion (Principal Investigator) Kurdi, Amanj (Co-investigator) Mueller, Tanja (Co-investigator); 01-Jan-2025 - 30-Jan-2026
Tackling antimicrobial resistance in Saudi Arabia: a multidisciplinary program to instigating evidence-based, theory-driven antimicrobial stewardship interventions using mixed-method approach: Elrggal, Mahmoud (CoPI) Kurdi, Amanj (Principal Investigator); A 48 months project funded by The Saudi Basic Science Initiative, Research Development and Innovation Authority (RDIA), ~£300K; 01-Jan-2025 - 30-Jan-2029
Real world effectiveness of Tirzepatide, Semaglutide, and Liraglutide effects on Lipid Profile, Blood Pressure, body weight, HbA1c and heart rate among diabetic and non-diabetic patients: A Systematic Review and meta-analysis of Observational Studies: Alotaibi, Eman (Principal Investigator) Kurdi, Amanj (Principal Investigator) Alotaibi, Badriah (Academic); 01-Jan-2024 - 30-Jan-2025

Back to staff profile

Contact

Professor Amanj Kurdi
Strathclyde Institute of Pharmacy and Biomedical Sciences

Email: amanj.baker@strath.ac.uk
Tel: 548 2181

Our faculties & departments

Engineering

Humanities & Social Sciences

Science

Strathclyde Business School